'Next decade is likely to be a golden era' for ASX shares in this sector

This stock is expected to deliver healthy returns according to a fund manager.

| More on:
A elder man and woman lean over their balcony with a cuppa, indicating share rpice movement for ASX retirement shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An investment team are very excited about the ASX healthcare share we're going to look at.

The ASX includes businesses from various healthcare sectors, including vaccine makers, private hospital operators, private health insurance providers, and device makers.

Aged care operator Regis Healthcare Ltd (ASX: REG) is one business worthy of attention, according to fund manager Blackwattle's small-cap investment team.

The company provides services to more than 9,000 older Australians through residential aged care homes, home care service hubs, day therapy and respite centres, and retirement villages.

The ASX healthcare share had a strong August, with the Regis share price increasing by 22% over the reporting season month. It reported revenue from services increased 29.9% to $1.01 billion, underlying operating profit (EBITDA) grew 28.7% to $107.2 million, and underlying net profit grew 24.7% to $35.6 million.

While the result was solid, Blackwattle is most excited about the outlook.

Improved outlook

The fund manager said the rise in the Regis Healthcare share price reflected a "significant change in the outlook for operators in the aged care industry."

Providing care and funding for aged care is a long-term issue for Australia – Blackwattle said governments have historically "kicked the can down the road for the next government to deal with".

Blackwattle then said:

But with the first baby boomers now moving into care the consequence of insufficient investment is upon us. The current government has no choice but to increase the funding of aged care operators to encourage the buildout of more beds. We believe the next decade is likely to be a golden era for aged care operators.

The Regis Healthcare share price jumped another 11% over the two days following the government's announcement that new aged care entrants will make larger means-tested contributions.

Regis is planning for growth

The ASX healthcare share expects to benefit over time from the "ageing population, improved workforce availability, additional government funding and strategic growth initiatives".

It plans to use its balance sheet and debt facility to pursue more acquisitions and greenfield development sites to grow shareholder value.

For example, in December 2023, it completed the acquisition of CPSM, which included five residential aged care homes in southeast Queensland with 644 beds for $75.2 million. The homes had an average occupancy of 97% in FY24.

The company also has a number of planned greenfield sites. The 112-bed Camberwell (VIC) site is in development, while the 123-bed Toowong (QLD) site is due to commence construction soon.

Future greenfield development locations include the 99-bed Belrose (NSW) and 101-bed Carlingford (NSW) sites, with development approval in place for both projects.

Overall, the ASX healthcare share believes there is insufficient new supply coming onto the market to meet the expected demand, which could push occupancy higher.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

2 ASX healthcare shares rocketing over 16% on Big US news

These companies are making their shareholders smile on Thursday. But why?

Read more »

Shot of a young scientist looking stressed while conducting medical research in a laboratory.
Healthcare Shares

Should you buy CSL shares after recent weakness?

Does the dip present a buying opportunity?

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Sigma shares up 25% in 2 days as Chemist Warehouse merger looks set

The deal continues to create tailwinds for Sigma shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Healthcare Shares

500 million reasons why ResMed shares are charging higher today

This growing company has big plans and is forecasting strong growth through to the end of the decade.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

'Exciting prospect': 2 ASX pharmaceutical shares to keep a close eye on

These companies have developed new drugs to treat vision loss and erectile dysfunction.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Guess which ASX 200 healthcare stock is up 12% on big Chemist Warehouse news

Investors appear to believe this news could be a sign that the deal will go ahead.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Healthcare Shares

Up 630% this year AND profitable! This small ASX healthcare share is glowing

Why has this stock delivered incredible returns this year? Let's find out.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Can the CSL share price push back above $300?

The biotech last traded there on September 9.

Read more »